No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Is Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans?
Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates
10-Q: Q3 2024 Earnings Report
Entera Bio Q3 2024 GAAP EPS $(0.08) Misses $(0.06) Estimate, Sales $42.00K Beat $40.00K Estimate
Entera Bio 3Q Loss/Shr 8c >ENTX